Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization

Hon Fong L Mark, Alaa M Afify, Bruce A. Werness, Sam Das, Seamus Mark, Mangala Samy

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Ovarian cancer is the leading cause of death from gynecologic malignancy among women in the United States. In 1997, there were nearly 27,000 ovarian cancer cases with over 14,000 deaths. Recent attempts at early detection of ovarian cancer have been aimed at the identification of biomarkers that would indicate an underlining malignant process or reflect the biological behavior of the tumor. Our previous studies revealed that chromosome 8 copy number abnormality, especially trisomy, is common in several cancers. Archival tissues from 24 cases of papillary serous ovarian carcinoma (10 stage I and 14 stage III) were analyzed by fluorescence in situ hybridization (FISH) with a chromosome 8-specific α-satellite probe (Oncor, Gaithersburg, MD). The analysis was done according to standard protocols of the Lifespan Academic Medical Center Cytogenetics Laboratory at Rhode Island Hospital. Twenty-one of 24 cases (87.5%) were found to be trisomic for chromosome 8, if a cutoff point of ≥15% cells with three signals is adopted. Overall, 80% of stage I and 93% of stage III tumors had trisomy 8. This study confirms the presence of a high frequency of trisomy 8 in both early and late stages of the disease and suggests that trisomy 8 may be an early event in the multistep process leading to ovarian cancer. It is of interest to note that a higher frequency of trisomy 8 was found in a higher stage of disease, consistent with our previous results on breast cancer. Thus, additional FISH studies of ovarian tumors for chromosome 8 copy number assessment may be warranted.

Original languageEnglish (US)
Pages (from-to)76-81
Number of pages6
JournalExperimental and Molecular Pathology
Volume66
Issue number1
DOIs
StatePublished - Apr 1999
Externally publishedYes

Fingerprint

Chromosomes
Chromosomes, Human, Pair 8
Fluorescence In Situ Hybridization
Ovarian Neoplasms
Fluorescence
Tumors
Neoplasms
Biomarkers
Trisomy
Early Detection of Cancer
Cytogenetics
Satellites
Tissue
Cause of Death
Trisomy Chromosome 8
Breast Neoplasms
Carcinoma

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization. / Mark, Hon Fong L; Afify, Alaa M; Werness, Bruce A.; Das, Sam; Mark, Seamus; Samy, Mangala.

In: Experimental and Molecular Pathology, Vol. 66, No. 1, 04.1999, p. 76-81.

Research output: Contribution to journalArticle

Mark, Hon Fong L ; Afify, Alaa M ; Werness, Bruce A. ; Das, Sam ; Mark, Seamus ; Samy, Mangala. / Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization. In: Experimental and Molecular Pathology. 1999 ; Vol. 66, No. 1. pp. 76-81.
@article{4d2fda062b3541b6a81ab07a9c622189,
title = "Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization",
abstract = "Ovarian cancer is the leading cause of death from gynecologic malignancy among women in the United States. In 1997, there were nearly 27,000 ovarian cancer cases with over 14,000 deaths. Recent attempts at early detection of ovarian cancer have been aimed at the identification of biomarkers that would indicate an underlining malignant process or reflect the biological behavior of the tumor. Our previous studies revealed that chromosome 8 copy number abnormality, especially trisomy, is common in several cancers. Archival tissues from 24 cases of papillary serous ovarian carcinoma (10 stage I and 14 stage III) were analyzed by fluorescence in situ hybridization (FISH) with a chromosome 8-specific α-satellite probe (Oncor, Gaithersburg, MD). The analysis was done according to standard protocols of the Lifespan Academic Medical Center Cytogenetics Laboratory at Rhode Island Hospital. Twenty-one of 24 cases (87.5{\%}) were found to be trisomic for chromosome 8, if a cutoff point of ≥15{\%} cells with three signals is adopted. Overall, 80{\%} of stage I and 93{\%} of stage III tumors had trisomy 8. This study confirms the presence of a high frequency of trisomy 8 in both early and late stages of the disease and suggests that trisomy 8 may be an early event in the multistep process leading to ovarian cancer. It is of interest to note that a higher frequency of trisomy 8 was found in a higher stage of disease, consistent with our previous results on breast cancer. Thus, additional FISH studies of ovarian tumors for chromosome 8 copy number assessment may be warranted.",
author = "Mark, {Hon Fong L} and Afify, {Alaa M} and Werness, {Bruce A.} and Sam Das and Seamus Mark and Mangala Samy",
year = "1999",
month = "4",
doi = "10.1006/exmp.1999.2241",
language = "English (US)",
volume = "66",
pages = "76--81",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization

AU - Mark, Hon Fong L

AU - Afify, Alaa M

AU - Werness, Bruce A.

AU - Das, Sam

AU - Mark, Seamus

AU - Samy, Mangala

PY - 1999/4

Y1 - 1999/4

N2 - Ovarian cancer is the leading cause of death from gynecologic malignancy among women in the United States. In 1997, there were nearly 27,000 ovarian cancer cases with over 14,000 deaths. Recent attempts at early detection of ovarian cancer have been aimed at the identification of biomarkers that would indicate an underlining malignant process or reflect the biological behavior of the tumor. Our previous studies revealed that chromosome 8 copy number abnormality, especially trisomy, is common in several cancers. Archival tissues from 24 cases of papillary serous ovarian carcinoma (10 stage I and 14 stage III) were analyzed by fluorescence in situ hybridization (FISH) with a chromosome 8-specific α-satellite probe (Oncor, Gaithersburg, MD). The analysis was done according to standard protocols of the Lifespan Academic Medical Center Cytogenetics Laboratory at Rhode Island Hospital. Twenty-one of 24 cases (87.5%) were found to be trisomic for chromosome 8, if a cutoff point of ≥15% cells with three signals is adopted. Overall, 80% of stage I and 93% of stage III tumors had trisomy 8. This study confirms the presence of a high frequency of trisomy 8 in both early and late stages of the disease and suggests that trisomy 8 may be an early event in the multistep process leading to ovarian cancer. It is of interest to note that a higher frequency of trisomy 8 was found in a higher stage of disease, consistent with our previous results on breast cancer. Thus, additional FISH studies of ovarian tumors for chromosome 8 copy number assessment may be warranted.

AB - Ovarian cancer is the leading cause of death from gynecologic malignancy among women in the United States. In 1997, there were nearly 27,000 ovarian cancer cases with over 14,000 deaths. Recent attempts at early detection of ovarian cancer have been aimed at the identification of biomarkers that would indicate an underlining malignant process or reflect the biological behavior of the tumor. Our previous studies revealed that chromosome 8 copy number abnormality, especially trisomy, is common in several cancers. Archival tissues from 24 cases of papillary serous ovarian carcinoma (10 stage I and 14 stage III) were analyzed by fluorescence in situ hybridization (FISH) with a chromosome 8-specific α-satellite probe (Oncor, Gaithersburg, MD). The analysis was done according to standard protocols of the Lifespan Academic Medical Center Cytogenetics Laboratory at Rhode Island Hospital. Twenty-one of 24 cases (87.5%) were found to be trisomic for chromosome 8, if a cutoff point of ≥15% cells with three signals is adopted. Overall, 80% of stage I and 93% of stage III tumors had trisomy 8. This study confirms the presence of a high frequency of trisomy 8 in both early and late stages of the disease and suggests that trisomy 8 may be an early event in the multistep process leading to ovarian cancer. It is of interest to note that a higher frequency of trisomy 8 was found in a higher stage of disease, consistent with our previous results on breast cancer. Thus, additional FISH studies of ovarian tumors for chromosome 8 copy number assessment may be warranted.

UR - http://www.scopus.com/inward/record.url?scp=0033002901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033002901&partnerID=8YFLogxK

U2 - 10.1006/exmp.1999.2241

DO - 10.1006/exmp.1999.2241

M3 - Article

C2 - 10331967

AN - SCOPUS:0033002901

VL - 66

SP - 76

EP - 81

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -